載入...
Study of the Efficacy, Safety and Tolerability of Low-Molecular-Weight Heparin vs. Unfractionated Heparin as Bridging Therapy in Patients with Embolic Stroke due to Atrial Fibrillation
BACKGROUND: Anticoagulation with adjusted dose warfarin is a well-accepted treatment for the prevention of recurrent stroke in patients with atrial fibrillation. Meanwhile, using bridging therapy with heparin or heparinoids before warfarin for initiation of anticoagulation is a matter of debate. We...
Na minha lista:
| 發表在: | J Vasc Interv Neurol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Zeenat Qureshi Stroke Research Center
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4925764/ https://ncbi.nlm.nih.gov/pubmed/27403222 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|